EFI Reports Second Quarter 2017 Results
Sep 11, 2017 11:14 am UTC| Business
FREMONT, Calif., Sept. 11, 2017 -- Electronics For Imaging, Inc. (Nasdaq:EFII), a world leader in customer-focused digital printing innovation, today announced its results for the second quarter of 2017. For the...
Galena Biopharma and BioVascular, Inc. Reaffirm GALE-401 Partnership
Sep 11, 2017 11:05 am UTC| Business
SAN RAMON, Calif., Sept. 11, 2017 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today announced it has reaffirmed...
Sep 11, 2017 11:02 am UTC| Business
Phase 1 clinical trial results in healthy subjects support cardiac safety of OBE022 Geneva, Switzerland and Boston, MA - 11 September, 2017 - ObsEva SA (NASDAQ: OBSV), a Swiss biopharmaceutical company focused on...
Sep 11, 2017 11:01 am UTC| Business
Shire's Investigational Subcutaneous C1 esterase inhibitor (C1 INH [Human]) Liquid for Injection (SHP616) Significantly Reduces Hereditary Angioedema Monthly Attack Rate Versus Placebo in a Phase 3 Pivotal Trial ...
Sep 11, 2017 11:00 am UTC| Business
CAMBRIDGE, Mass. and OXFORD, United Kingdom, Sept. 11, 2017 -- Summit Therapeutics (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C....
Pilgrim’s Acquires Moy Park for $1.3 Billion (£1.0 Billion)
Sep 11, 2017 11:00 am UTC| Business
Creates Leading Global Poultry and Prepared Foods Company Increases Pilgrim’s Geographic Diversity by Expanding Operations Across the UK and Continental Europe Transaction Expected to be Immediately Accretive to...
Stemline Therapeutics Presents SL-801 Phase 1 Data at ESMO 2017
Sep 11, 2017 11:00 am UTC| Business
NEW YORK, Sept. 11, 2017 -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced the presentation of clinical data...